APA (7th ed.) Citation

A, K., S, X., H, Y., D, D., J, T., RHY, J., . . . SM, S. (2018). GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. Nature communications, 9(1), 5154. https://doi.org/10.1038/s41467-018-07644-6

Chicago Style (17th ed.) Citation

A, Kazi, et al. "GSK3 Suppression Upregulates β-catenin and C-Myc to Abrogate KRas-dependent Tumors." Nature Communications 9, no. 1 (2018): 5154. https://doi.org/10.1038/s41467-018-07644-6.

MLA (9th ed.) Citation

A, Kazi, et al. "GSK3 Suppression Upregulates β-catenin and C-Myc to Abrogate KRas-dependent Tumors." Nature Communications, vol. 9, no. 1, 2018, p. 5154, https://doi.org/10.1038/s41467-018-07644-6.